The sodium alginate market offers opportunities in food, pharma, and biomed sectors due to its natural, non-toxic appeal. Consumer trends toward sustainable materials, advancements in green technology ...
Texas Biomed expanding work — and revenue base — with Big Pharma; seen as key to its competitiveness
Before the COVID-19 pandemic, Texas Biomedical Research Institute had established itself as a go-to researcher of infectious diseases, along with therapeutics and vaccines to combat them. It was ...
NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine ...
Traditionally, medtech companies have utilized a sales-based model, but many of them are now transitioning to recurring-revenue models like subscription-based services or device-as-a-service. The need ...
New Haven, Conn.-based Yale University is partnering with pharmaceutical company Boehringer Ingelheim to launch a Biomedical Data Science Fellowship program aimed at innovating drug discovery. A May ...
Nanoparticle technology offers significant market opportunities in pharmaceuticals and biomedicine, enhancing drug delivery, solubility, and targeted therapy. This field supports advancements in ...
Lifecore Biomedical Inc, a fully integrated contract development and manufacturing organization (CDMO), announced that it has signed a contract development and manufacturing organization master ...
TOKYO--(BUSINESS WIRE)--Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan, President and Representative Director: Daikichiro Kobayashi) and the Foundation for Biomedical Research and Innovation ...
CHASKA, Minn., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (LFCR) (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and ...
Last week, The European Commission authorizing Comirnaty, a third version of the updated COVID-19 vaccine from Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) to be used in EU countries' ...
Lifecore Biomedical shares rose after the company said it signed a master services agreement with a large pharmaceutical customer. The stock rose 12% to $8.62 on Wednesday. Shares are up 16% this year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback